Adding nimotuzumab to post-surgery adjuvant cisplatin-based chemoradiotherapy does not improve survival outcomes in patients with HNSCC.

Kura Oncology to host a virtual investor event today, October 18, 2025, at 10:30 a.m. PT / 1:30 p.m. ET / 7:30 p.m. CEST ...

The combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) with chemotherapy did not help patients with metastatic ...

Regeneron Pharmaceuticals recently received U.S. FDA approval and a positive opinion from the European Medicines Agency's ...

Although exposure to ultraviolet rays is a primary cause of skin cancer, factors such as your age, sex, and smoking habits also may contribute to developing this health issue.

New research published in Cell finds the existence of craters on the surface of melanoma cells that serve as immune hubs, ...

Positive opinion based on results of Phase 3 C-POST trial that show Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence ...

Regeneron Pharmaceuticals said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its blockbuster cancer drug Libtayo for certain ...

Regeneron (REGN) announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion for ...

Keaton battled skin cancer years before she died. Here’s what we know about her health, which a friend said ‘declined very ...

Kidman Park man, Joshua Giorgio died surrounded by family and friends on October 4 this year after a brave battle with oral ...

With the 2025 European Society of Medical Oncology (ESMO) Congress kicking off on Friday, October 17, in Berlin, Germany, Targeted Oncology is bringing you background on the most exciting abstracts ...